STUB1 and myelodysplastic syndrome: A study by Frick et al., including 50% AML patients, reported that CHIP mutations in alloSCT donors associated with an increased incidence of chronic Graft‐versus‐Host‐Disease and a higher risk of developing donor cell leukemia, while MDS or AML patients whose donors carried a CHIP mutation showed better OS.29